Xanthelasma Palpebrarum
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age > 18 years, < 65 years; 2. It met the diagnostic criteria of xanthoma and the lesions were bilateral symmetrical; 3. Agree to cooperate with the completion of treatment and follow-up visits, and agree to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Medical history/surgical history of any clinical systemic disease that is out of control and serious or may affect treatment and effectiveness evaluation, such as circulatory system, nervous system, blood system, immune system, psychiatric system, etc. 2. Lesions and surrounding scars, congenital malformations and other appearance characteristics that are not conducive to observation and evaluation, or have previously undergone eye and periocular plastic surgery/repair, or related operations that will affect the normal structure of the eye skin; 3. Intraocular or skin infections and other active skin diseases; 4. Receiving other facial rejuvenation treatments or sun exposure with or without protective measures during treatment; 5. Participants who participated in or are participating in clinical trials of other interventional drugs or medical devices within 3 months prior to screening; 6. Received other phototherapy or oral isotretinoic acid, minocycline and other photosensitive drugs 3 months before screening; 7. The investigator believes that the subjects have other conditions that may affect their compliance or are not suitable to participate in the study; 8. Those who have a history of drug abuse, drug use or alcohol dependence before screening; 9. Subjects who were assessed by the study physician as unsuitable for enrollment.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Reoccurrence rate;complications;Patient satisfaction; | — |
Primary
| Measure | Time frame |
|---|---|
| clearance rate; | — |
Countries
China
Contacts
Dematology Hospital of Southern Medical University